Anti-biofilm peptides as a new weapon in antimicrobial warfare

Curr Opin Microbiol. 2016 Oct:33:35-40. doi: 10.1016/j.mib.2016.05.016. Epub 2016 Jun 16.

Abstract

Microorganisms growing in a biofilm state are very resilient in the face of treatment by many antimicrobial agents. Biofilm infections are a significant problem in chronic and long-term infections, including those colonizing medical devices and implants. Anti-biofilm peptides represent a very promising approach to treat biofilm-related infections and have an extraordinary ability to interfere with various stages of the biofilm growth mode. Anti-biofilm peptides possess promising broad-spectrum activity in killing both Gram-positive and Gram-negative bacteria in biofilms, show strong synergy with conventional antibiotics, and act by targeting a universal stringent stress response. Understanding downstream processes at the molecular level will help to develop and design peptides with increased activity. Anti-biofilm peptides represent a novel, exciting approach to treating recalcitrant bacterial infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / pharmacology*
  • Bacterial Infections / drug therapy*
  • Biofilms / drug effects*
  • Biofilms / growth & development*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / metabolism
  • Drug Synergism
  • Escherichia coli / drug effects*
  • Microbial Sensitivity Tests
  • Prostheses and Implants / microbiology
  • Prosthesis-Related Infections / drug therapy
  • Prosthesis-Related Infections / microbiology
  • Quorum Sensing / physiology
  • Staphylococcus aureus / drug effects*

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • bis(3',5')-cyclic diguanylic acid
  • Cyclic GMP